Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-096664·HBM Healthcare Investments (Cayman) Ltd.
Schedule 13G ownership disclosure
Immuneering Corp
Class A Common Stock, par value $0.001 per share · CUSIP: 45254E107
Event date: 2025-09-26
- Filing-level shares
- 3,646,304.00
- Percent of class
- 5.7%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 3,646,304.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-096664
- Form type
- SCHEDULE 13G
- Filer
- HBM Healthcare Investments (Cayman) Ltd.
- CIK
- CIK 1232258
- Filed
- Oct 03, 2025
- Reporting period
- Sep 26, 2025
- Description
- Schedule 13G beneficial ownership